EpiBone's last reported valuation, Jan 2020. Nothing priced has surfaced since.
- ·The complete investor list: 50 names
- ·Watch EpiBone: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
EpiBone funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Seed Round | $4.3M | ▮ | ▮ |
| Dec 2022 | Early Stage VC | $18.5M | ▮ | ▮ |
| Feb 2021 | Later Stage VC | $750K | ▮ | ▮ |
| Jan 2020 | Early Stage VC | $24.3M | ▮ | ▮ |
Membership and data by Private Market View
EpiBone valuation
EpiBone's last reported valuation was $44.3 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.
How much has EpiBone raised?
EpiBone has raised $71.1 million across 4 recorded rounds since 2020. The largest was a $750,000 later-stage round in Feb 2021; the most recent was a $4.3 million seed round in Sep 2025.
EpiBone has filed 3 Form Ds with the SEC since 2020, most recently in Dec 2022 ($18.5 million sold to 51 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy EpiBone shares, reporting $1.1 million sold to 19 investors, per SEC Form D filings (most recent Mar 2026).
Comparable companies
Comparable other healthcare technology systems names by valuation on PrivateMarketView: August Health ($65 million), BellaLift ($43 million) and Welltory ($29 million).
How EpiBone's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For EpiBone, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about EpiBone
- What is EpiBone worth?
- EpiBone is valued at $44.3M as of Oct 2026. EpiBone's last reported valuation, Jan 2020. Nothing priced has surfaced since.
- How much has EpiBone raised?
- EpiBone has raised $71.1M in total funding across 4 recorded rounds.
- When did EpiBone last raise?
- EpiBone last raised in Sep 2025 (Seed Round), raising $4.3M.